Peer-reviewed originale forskningsartikler: 20
Stene L. Accelerator hypothesis [internet]. 2014 [cited 2014 Jun 17]; Diapedia 21040851194 rev. no. 7. Available from: http://www.diapedia.org/type-1-diabetes-mellitus/21040851194/accelerator-hypothesis
L Krogvold og K Dahl-Jørgensen. Diabeteshåndboken, ISBN: P9788205399167, Vaaler og Møinichen (red.). Kap. 5; Arv, miljø og mekanismer ved utvikling av type 1 diabetes.
Inviterte foredrag ved internasjonale kongresser:
Knut Dahl-Jørgensen. Cardiovascular disease outcomes in childhood onset diabetes. ISPAD Annual Meeting, Toronto, September 2014.
Knut Dahl-Jørgensen: What causes type 1 diabetes? Enterovirus – Results from the DiViD study. Barndiabetesfonden 25th Anniversary Conference, Linköping, October 2014.
Lars Krogvold. The DiViD Study - Pancreatic Biopsies. nPOD annual meeting, Atlantic Beach, Jacksonville, USA. February 2014.
LC Stene. Overview of clinical studies: What have they taught us around the role of diet in susceptibility to islet autoimmunity and T1D?: Maternal diet and prenatal environment. Invited presentation at the Juvenile Diabetes Research Foundation (JDRF) sponsored workshop: Role of Infant Diet in Susceptibility/Resistance to Type 1 Diabetes, September 15, 2014, Vienna Austria.
LC Stene. Type 1 diabetes epidemiology. Invited presentation on the 6th National Diabetes Symposium, 6th National Diabetes Symposium, Type 1 Diabetes in Childhood and Adolescence, November 8th, Jericho and November 9th, Gaza City, Palestine, 2014.
International Scientific Awards:
Knut Dahl-Jørgensen. The Swedish Childhood Diabetes Foundation’s Nordic Johnny Ludvigsson-Prize 2014.
Vibeke Gagnum. ISPAD 2014 award, Best Oral presentation for Clinical Science.
Mortality in a nationwide, population-based cohort of childhood-onset type 1 diabetes in Norway. Oral presentation at the 40th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD), Toronto, Canada 3.-6. Sept., 2014.
Ingvild Menes Sørensen, 24.01.2014: “Biomarkers for intrauterine environment and risk of childhood type 1 diabetes.”
Magnhild P. Kolsgaard, 30.04.2014: “Cardiometabolic risk factors and obesity treatment in children and adolescents. The Oslo Adiposity Intervention Study”
Kari Anne Sveen, 04.06.2014: “Long-term vascular and neurological complications in type 1 diabetes – Clinical aspects and biological markers.”
Ingvild Eidem, 11.06.2014: “Pregnancy outcomes in women with type 1 diabetes in Norway.”
Selekterte publikasjoner fra gruppen:
T. Skrivarhaug, L.C. Stene, A.K. Drivvoll, H.Strøm, G.Joner.
Incidence of Type 1 diabetes in Norway among individuals aged 0-14 years, 1989-2012: Has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia 2014 Jan;57(1):57-62. Epub 2013 Oct 23.
Krogvold L, Edwin B, Buanes T, Frisk G, Skog O, Anagandula M, Korsgren O, Undlien D, Eike M, Richardson SJ, Leete P, Morgan NG, Oikarinen S, Oikarinen M, Laiho JE, Hyöty H, Ludvigsson J, Hanssen KF, Dahl-Jørgensen K. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2014 Nov 24.
Lund-Blix NA, Stene LC, Rasmussen T, Torjesen PA, Andersen LF, Rønningen KS. Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: the MIDIA study. Diabetes Care 2014 (epub Nov 24).
Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents
Diabetologia, 63 (8), 1530-1541
The DISABKIDS generic and diabetes-specific modules are valid but not directly comparable between Denmark, Sweden, and Norway
Pediatr Diabetes, 21 (5), 900-908
International benchmarking in type 1 diabetes: Large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-A quality registry study
Pediatr Diabetes, 21 (4), 621-627